Patent 11248054 was granted and assigned to Bluefin Biomedicine on February, 2022 by the United States Patent and Trademark Office.
Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.